Your browser doesn't support javascript.
loading
20(S)-protopanaxadiol regio-selectively targets androgen receptor: anticancer effects in castration-resistant prostate tumors.
Ben-Eltriki, Mohamed; Deb, Subrata; Hassona, Mohamed; Meckling, Gray; Fazli, Ladan; Chin, Mei Yieng; Lallous, Nada; Yamazaki, Takeshi; Jia, William; Rennie, Paul S; Cherkasov, Artem; Tomlinson Guns, Emma S.
Afiliação
  • Ben-Eltriki M; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
  • Deb S; Department of Experimental Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Hassona M; Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, FL, USA.
  • Meckling G; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
  • Fazli L; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
  • Chin MY; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
  • Lallous N; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Yamazaki T; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
  • Jia W; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
  • Rennie PS; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
  • Cherkasov A; Department of Surgery and Brain Research Centre, University of British Columbia, Vancouver, BC, Canada.
  • Tomlinson Guns ES; The Vancouver Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada.
Oncotarget ; 9(30): 20965-20978, 2018 Apr 20.
Article em En | MEDLINE | ID: mdl-29765513

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos